REQUIP NEWS HIGHLIGHTS
Media Articles Related to Requip (Ropinirole)
Parkinson's Disease
Source: MedicineNet levodopa-carbidopa Specialty [2005.12.17]
Transdermal Rotigotine Patch Safe, Effective in Early Idiopathic Parkinson's Disease
Source: Medscape Pharmacotherapy Headlines [2004.06.17]
Surgical Technique Halts Cell Loss, Parkinson's Researchers Find
Source: Neurology / Neuroscience News From Medical News Today [2008.09.04]
Stroke And Parkinson's Patients Aided By New Sensory Devices
Source: Medical Devices / Diagnostics News From Medical News Today [2008.09.01]
Using Plastic Coatings To Help Medical Implants Connect With Neurons
Source: Eye Health / Blindness News From Medical News Today [2008.08.22]
Published Studies Related to Requip (Ropinirole)
Rotigotine transdermal patch in early Parkinson's disease: a randomized, double-blind, controlled study versus placebo and ropinirole. [2007.12]
Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa. [2007.12]
Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease. [2007.04.03]
A comparison of sumanirole versus placebo or ropinirole for the treatment of patients with early Parkinson's disease. [2007.03.15]
The weight of evidence for ropinirole in restless legs syndrome. [2006.10]
Clinical Trials Related to Requip (Ropinirole)
A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's [Completed]
Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome) [Completed]
Treating Sexual Dysfunction From SSRI Medication: a Study Comparing Requip CR to Placebo [Active, not recruiting]
Long-Term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164 [Active, not recruiting]
An Open-Label Continuation Study Evaluating the Long-Term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease [Active, not recruiting]
|
